Prevalence, Incidence and Prognostic Implications of Left Bundle Branch Block in Patients with Chronic Coronary Syndromes (From the CLARIFY Registry)

• Published in: The American journal of cardiology 2021-07, Vol.150, p.40-46
• Main Authors: Darmon, Arthur, Ducrocq, Gregory, Elbez, Yedid, Popovic, Batric, Sorbets, Emmanuel, Ferrari, Roberto, Ford, Ian, Tardif, Jean-Claude, Tendera, Michal, Fox, Kim M., Steg, Philippe Gabriel
• Format: Article
• Language: English
• Subjects: Angioplasty; Cardiac arrhythmia; Cardiovascular disease; Cardiovascular diseases; Cerebral infarction; Confidence intervals; Congestive heart failure; Coronary artery; Coronary artery disease; Coronary vessels; Death; Disorders; Ejection fraction; Fibrillation; Health risks; Heart attacks; Heart failure; Heart surgery; Hospitalization; Hypertension; Implantation; Ischemia; Mortality; Multivariate analysis; Myocardial infarction; Pacemakers; Risk; Stroke; Surgical implants
• ISSN: 0002-9149; 1879-1913
• DOI: 10.1016/j.amjcard.2021.03.047

Left Bundle Branch Block (LBBB) is a frequently encountered electrical abnormality in patients with chronic (more than 3 months after myocardial infarction, or evidence of coronary artery disease with ischemia) coronary syndromes (CCS), but its prognostic significance remains unclear. We aimed to describe the prevalence, incidence and five-year outcomes of LBBB in outpatients with CCS using the CLARIFY registry. Main outcome was a composite of CV death, MI or stroke. Secondary outcomes included all cause death, hospitalization for heart failure (HF) and permanent pacemaker implantation. Among 23.544 patients with available information regarding LBBB status at baseline, 1.041 (4.4%) had LBBB at baseline and 1.015 (4.5%) patients developed a new LBBB during 5-year follow-up. In multivariate analysis, LBBB at baseline was not associated with the composite outcome of CV death, MI or stroke (HR 1.06, 95% CI [0.86 – 1.31], p = 0.67) or the risk of all-cause death (HR 1.07, 95% CI [0.87 – 1.32], p = 0.52) but was significantly associated with a higher risk of hospitalization for HF (HR 1.50, 95% CI [1.21 – 1.88], p < 0.001) and permanent pacemaker implantation (HR 2.11, 95% CI [1.45 – 3.07], p < 0.001). The main factors associated with new-onset LBBB were male sex (HR 0.8 [0.66-0.98], p = 0.028) history of atrial fibrillation (HR 1.29, 95% CI [1.01 – 1.64], p = 0.04), CABG (HR 1.27, [1.08 – 1.51], p = 0.004) and MI (HR 1.19, 95% CI [1.01 – 1.40], p = 0.034). In conclusion, in a contemporary registry of outpatients with CCS, the prevalence of LBBB was 4.4% and the additional 5-years incidence 6.2%. LBBB, in itself, was not associated with a higher risk of major adverse cardiovascular events or all cause mortality. It was however an independent predictor of risk of hospitalization for heart failure and permanent pacemaker implantation.